Filing Details
- Accession Number:
- 0001225208-25-001969
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-19 16:23:45
- Reporting Period:
- 2025-02-18
- Filing Date:
- 2025-02-19
- Accepted Time:
- 2025-02-19 16:23:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1595612 | J. Daniel Brennan | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-18 | 2,900 | $104.08 | 247,248 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-18 | 14,630 | $104.67 | 232,618 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-02-19 | 18,533 | $24.55 | 251,151 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-19 | 16,865 | $17.26 | 268,016 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-19 | 15,642 | $27.09 | 283,658 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-19 | 9,483 | $40.12 | 293,141 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-19 | 67,333 | $105.24 | 225,808 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-19 | 15,642 | $0.00 | 15,642 | $27.09 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-19 | 9,483 | $0.00 | 9,483 | $40.12 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-19 | 16,865 | $0.00 | 16,865 | $17.26 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-19 | 18,533 | $0.00 | 18,533 | $24.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 31,285 | 2028-02-15 | No | 4 | M | Direct | |
| 37,934 | 2029-02-21 | No | 4 | M | Direct | |
| 0 | 2026-02-22 | No | 4 | M | Direct | |
| 37,067 | 2027-02-28 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.35 to $104.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.37 to $105.09, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.46, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
Billionaire Hedge Funds
